Poland· PL-100484968

Veinofytil

A hippocastani semen product containing hippocastani seminis extractum siccum, registered in Poland by Tilman S.A.. The same ATC class is registered in 7 of our 19 countries.

ATC C05CX03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVeinofytilATCC05CX03REGISTER NO.PL-100484968PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Hippocastani semen is registered in 7 of 19 countries.

Countries holding a registration under ATC C05CX03 (hippocastani semen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Hippocastani semen · ATC C05CX03

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Hippocastani seminis extractum siccum
Manufacturer
Tilman S.A.
Country
Poland (PL)
ATC code
C05CX03
ATC class
Hippocastani semen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991537876
  • gtin
    05909991537883

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Hippocastani semen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hippocastani semen products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Venen-Aktiv
  • Italy · Flebostasin R

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f74eec59-4b14-43c6-b46b-dc659ef9c2d6
GET /v1/drugs/f74eec59-4b14-43c6-b46b-dc659ef9c2d6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki dojelitowe",
  "source": "urpl",
  "strength": "21 mg glikozydów triterpenowych w przeliczeniu na protoescygeninę",
  "packaging": "05909991537876 ¦ OTC ¦ 154260\n42 tabl.\n05909991537883 ¦ OTC ¦ 154261\n98 tabl.",
  "substance": "Hippocastani seminis extractum siccum 192,1 - 257,9 mg",
  "common_name": "Hippocastani seminis extractum siccum",
  "pl_product_id": "100484968",
  "pozwolenie_nr": "28354",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about hippocastani semen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.